Jaeck D, Bachellier P, Guiguet M, Boudjema K, Vaillant J C, Balladur P, Nordlinger B
Centre de Chirurgie Viscérale et de Transplantation, Hôpital de Hautepierre, Strasbourg, France.
Br J Surg. 1997 Jul;84(7):977-80. doi: 10.1002/bjs.1800840719.
The aim of this study was to analyse characteristics of patients who survived more than 5 years after liver resection of colorectal metastases.
A multicentre retrospective study collected 1818 patients who underwent curative resection of hepatic metastases between 1959 and 1991. Among the 747 patients operated on before 1987, 102 survived longer than 5 years, and were compared with patients who survived less than 5 years.
Three risk factors proved independently significant in multivariate analysis between the two groups: serosa infiltration (P = 0.003), involvement of peritumoral lymph nodes around the primary colorectal tumour (P = 0.04), and a liver resection margin of less than 1 cm (P = 0.02). There was no significant difference for other parameters studied (location of primary tumour, location, number and size of metastases, type of resection). A trend towards a shorter survival of patients with increased carcinoembryonic antigen serum level was observed.
Resection of colorectal hepatic metastases can provide long-term survival even in patients with poor prognostic factors. It seems justified to undertake resection of colorectal liver metastases whenever it may be performed safely as a curative treatment.
本研究旨在分析结直肠癌肝转移灶切除术后存活超过5年患者的特征。
一项多中心回顾性研究收集了1959年至1991年间接受肝转移灶根治性切除的1818例患者。在1987年前接受手术的747例患者中,102例存活超过5年,并与存活不足5年的患者进行比较。
多因素分析显示,两组间有三个危险因素具有独立显著性:浆膜浸润(P = 0.003)、原发性结直肠癌周围瘤周淋巴结受累(P = 0.04)以及肝切除切缘小于1 cm(P = 0.02)。所研究的其他参数(原发肿瘤位置、转移灶位置、数量和大小、切除类型)无显著差异。观察到癌胚抗原血清水平升高的患者生存时间有缩短趋势。
即使对于预后不良因素的患者,结直肠癌肝转移灶切除术也可提供长期生存。只要能安全地进行结直肠癌肝转移灶切除术作为根治性治疗,那么进行该手术似乎是合理的。